SCHEMBL18796308

SCHEMBL18796308

Cc1nc2ccccc2nc1Oc1ccc(Br)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.47
▸ KDR P35968 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KDM4E B2RXH2 6/20 0.39
▸ POLB P06746 1/20 0.39
▸ HRH4 Q9H3N8 4/20 0.38
▸ HPGD P15428 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ SLC6A4 P31645 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18292683 0.83 HRH4 (0.46) EGFRL3MBTL1TSHRCYP1A2CYP2C9
SCHEMBL18796028 0.78 SCD (0.43) L3MBTL1TSHRKDM4EPOLBHPGD
SCHEMBL18796467 0.77 L3MBTL1 (0.40) EGFRL3MBTL1TSHRCYP1A2CYP2C9
SCHEMBL18796232 0.75 POLB (0.42) L3MBTL1TSHRKDM4EPOLBHPGD
SCHEMBL18795957 0.75 NQO2 (0.50) L3MBTL1TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL18796145 0.74 HTT (0.64) EGFRKDRL3MBTL1CYP1A2CYP2C9
SCHEMBL18796221 0.74 L3MBTL1 (0.42) L3MBTL1TSHRKDM4EPOLBHPGD
SCHEMBL18796404 0.73 LCK (0.52) L3MBTL1TSHRCYP1A2KDM4EPOLB
SCHEMBL31527923 0.72 EGFR (0.48) EGFRKDR
SCHEMBL2829829 0.72 EGFR (0.44) EGFRKDRCYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 — — EP disclosed
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-06-16 — — US disclosed
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-08-01 — — US disclosed
EP-3368514-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES Bayer CropScience Aktiengesellschaft (DE) 2018-09-05 — — EP disclosed
WO-2017072283-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues PIK3C3, ERG28, DDT EGFR 4543/4885KDR 4276/4885L3MBTL1 2453/4885
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES PIK3C3, ERG28, DDT EGFR 4543/4885KDR 4276/4885L3MBTL1 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback